{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:39:00Z","timestamp":1760452740090},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Medical Information Framework"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.brainres.2016.09.022","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T17:19:08Z","timestamp":1474651148000},"page":"11-16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Cerebrospinal fluid-induced retardation of amyloid \u03b2 aggregation correlates with Alzheimer's disease and the APOE \u03b54 allele"],"prefix":"10.1016","volume":"1651","author":[{"given":"E.R.","family":"Padayachee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Portelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bor\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cukalevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Linse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2016.09.022_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000026206","article-title":"Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project","volume":"18","author":"Andreasen","year":"1999","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.brainres.2016.09.022_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2217\/bmm.12.44","article-title":"Analytical aspects of molecular Alzheimer\u2019s disease biomarkers","volume":"6","author":"Andreasson","year":"2012","journal-title":"Biomark. Med."},{"key":"10.1016\/j.brainres.2016.09.022_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tips.2013.12.005","article-title":"Chemical kinetics for drug discovery to combat protein aggregation diseases","volume":"35","author":"Arosio","year":"2014","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.brainres.2016.09.022_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","article-title":"The genetics of Alzheimer\u2019s disease","volume":"107","author":"Bertram","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.brainres.2016.09.022_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2016.09.022_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0005-2760(94)00232-N","article-title":"Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid","volume":"1255","author":"Borghini","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2016.09.022_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0022-510X(96)00123-2","article-title":"Effect of cerebrospinal fluid from normal and Alzheimer\u2019s patients with different apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein","volume":"141","author":"Chauhan","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2016.09.022_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nsmb.2971","article-title":"A molecular chaperone breaks the catalytic cycle that generates toxic Abeta oligomers","volume":"22","author":"Cohen","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.brainres.2016.09.022_bib9","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2016.09.022_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/1097-0029(20000815)50:4<316::AID-JEMT11>3.0.CO;2-E","article-title":"Influence of lipoproteins on microglial degradation of Alzheimer\u2019s amyloid beta-protein","volume":"50","author":"Cole","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.brainres.2016.09.022_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.brainres.2016.09.022_bib12","doi-asserted-by":"crossref","first-page":"30001","DOI":"10.1074\/jbc.274.42.30001","article-title":"Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-\/-), and human apoE transgenic mice","volume":"274","author":"Fagan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2016.09.022_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jmb.2009.12.016","article-title":"The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42","volume":"396","author":"Finder","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.brainres.2016.09.022_bib14","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1207022109","article-title":"Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer\u2019s disease","volume":"109","author":"Frieden","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2016.09.022_bib15","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1021\/bi5008172","article-title":"The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation","volume":"53","author":"Garai","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainres.2016.09.022_bib16","first-page":"357","article-title":"The amyloid deposits in Alzheimer\u2019s disease: their nature and pathogenesis","volume":"2","author":"Glenner","year":"1984","journal-title":"Appl. Pathol."},{"key":"10.1016\/j.brainres.2016.09.022_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCRESAHA.107.149666","article-title":"Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase","volume":"101","author":"Gustafsson","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.brainres.2016.09.022_bib18","doi-asserted-by":"crossref","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2016.09.022_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/cn900015v","article-title":"Amyloid beta-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process","volume":"1","author":"Hellstrand","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.brainres.2016.09.022_bib20","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer\u2019s disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.brainres.2016.09.022_bib21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1006\/bbrc.1994.2788","article-title":"The soluble form of Alzheimer\u2019s amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma","volume":"205","author":"Koudinov","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2016.09.022_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1006\/bbrc.1996.0940","article-title":"Biochemical characterization of Alzheimer\u2019s soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins","volume":"223","author":"Koudinov","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2016.09.022_bib23","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1046\/j.1471-4159.1998.70052070.x","article-title":"Nascent astrocyte particles differ from lipoproteins in CSF","volume":"70","author":"Ladu","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2016.09.022_bib24","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","article-title":"Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid","volume":"270","author":"Ladu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2016.09.022_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbalip.2011.11.005","article-title":"Preferential interactions between ApoE-containing lipoprotiens and A\u03b2 revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift","volume":"1821","author":"Ladu","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.brainres.2016.09.022_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2016.09.022_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.brainres.2016.09.022_bib28","doi-asserted-by":"crossref","first-page":"31066","DOI":"10.1074\/jbc.M114.595124","article-title":"Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Abeta42) aggregates leads to sub-stoichiometric inhibition of amyloid formation","volume":"289","author":"Mansson","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2016.09.022_bib29","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2016.09.022_bib30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease","volume":"34","author":"Mckhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2016.09.022_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Mckhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2016.09.022_bib32","doi-asserted-by":"crossref","first-page":"II21","DOI":"10.1002\/clc.4960221405","article-title":"Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy","volume":"22","author":"Otvos","year":"1999","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.brainres.2016.09.022_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer\u2019s disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2016.09.022_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","article-title":"Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease","volume":"120","author":"Portelius","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2016.09.022_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer\u2019s disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2016.09.022_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/biof.1202","article-title":"HDL particle subpopulations: focus on biological function","volume":"41","author":"Rached","year":"2015","journal-title":"Biofactors"},{"key":"10.1016\/j.brainres.2016.09.022_bib37","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2016.09.022_bib38","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","article-title":"A facile method for expression and purification of the Alzheimer\u2019s disease-associated amyloid beta-peptide","volume":"276","author":"Walsh","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.brainres.2016.09.022_bib39","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2016.09.022_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ana.410340422","article-title":"Cerebrospinal fluid inhibits Alzheimer beta-amyloid fibril formation in vitro","volume":"34","author":"Wisniewski","year":"1993","journal-title":"Ann. Neurol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899316306515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899316306515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T01:38:43Z","timestamp":1536370723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899316306515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"alternative-id":["S0006899316306515"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2016.09.022","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid-induced retardation of amyloid \u03b2 aggregation correlates with Alzheimer's disease and the APOE \u03b54 allele","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2016.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}